Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Fri, 11.09.2026
DocMorris AG
DocMorris AG
/ Key word(s): Bond
DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
11.09.2026 / 19:44 CET/CEST
Frauenfeld, 11 September 2026
Press release
DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
The New Bonds have [ … ]
Fri, 11.09.2026
Information Services Department, Hong Kong SAR Government
EQS Newswire / 11/09/2026 / 16:30 CET/CEST
HONG KONG SAR - Media OutReach Newswire - 11 September 2026 - The 11th Belt and Road Summit was successfully held at the Hong Kong Convention & Exhibition Centre (September 9–10), attracting over 6,200 political and business elites from more than 70 countries and regions under the Belt and Road In [ … ]
Fri, 11.09.2026
Deutsche Postbank Funding Trust III
Deutsche Postbank Funding Trust III hereby announces that the semi-annual report as of June 30th, 2026 pursuant to Section 5:25c of the Netherlands Financial Supervision Act (Wet op het financieel toezicht) is available at: https://investor-relations.db.com/creditors/prospectuses/reports-deutsche-postbank-funding-trusts
Language: English
Company: D [ … ]
Fri, 11.09.2026
Thailand Board of Investment (BOI)
EQS Newswire / 11/09/2026 / 15:00 CET/CEST
BANGKOK, THAILAND – Media OutReach Newswire – 11 September 2026 – Thailand is fast-tracking regulatory approval for $3.66 billion (121 billion baht) in strategic industrial investment. The move is part of a broader overhaul of the national investment regime, aimed at anchoring high-value global supply [ … ]
Fri, 11.09.2026
Österreichische Post AG
AUSTRIAN POST REACHES AGREEMENT WITH THE REPUBLIC OF AUSTRIA TO PAY COMPENSATION FOR SOCIAL CONTRIBUTIONS RELATING TO CIVIL SERVANTS FOR THE YEARS 1996 TO 2008
Vienna, 11 September 2026 – Austrian Post has reached an agreement with the Austrian Finanzprokuratur, acting as the legal representative of the Republic of Austria (Austrian Federal Chance [ … ]
Fri, 11.09.2026
Vinhomes
EQS Newswire / 11/09/2026 / 14:15 CET/CEST
HANOI, VIETNAM – Media OutReach Newswire – 11 September 2026 – As Asia emerges as the center of global urbanization, Vinhomes is advancing a model of city-building that weaves residential, commercial, educational, healthcare, and green infrastructure into a single, integrated ecosystem. With projects [ … ]
Fri, 11.09.2026
Cantourage Group SE
Company Name:
Cantourage Group SE
ISIN:
DE000A3DSV01
Reason for the research:
Update
Recommendation:
Kaufen
from:
11.09.2026
Target price:
€11
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Cantourage Group SE (ISIN: DE000A3DSV01) ver [ … ]
Fri, 11.09.2026
Vulcan Energy Resources Limited
Vulcan secures second lithium production licence for Lionheart Project
Key highlights
Second lithium production licence issued to Vulcan in the Upper Rhine Valley Brine Field by the Mining Authority of the German state of Rhineland-Palatinate
Satisfaction of further milestone towards the 2028 Lionheart production target which remains o [ … ]
Fri, 11.09.2026
PAUL Tech AG
AD-HOC RELEASE
Public disclosure of inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation – MAR)PAUL Tech AG seeks a two-year extension of the term of the EUR 35 million bondMannheim, 11 September 2026 – The management board of PAUL Tech AG as issuer ("Issuer") of the EUR 35m [ … ]
Fri, 11.09.2026
Galimedix, Inc.
Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Kensington, MD, USA, and Munich/Martinsried, Germany, September 11, 2026 – Galimedix Therapeutics, Inc. (“Galimedix”), a Phase 2 clinical-stage biotechnology company developing novel oral and topical neuroprotecti [ … ]
